Between the high cost and testing hurdles, molnupiravir may not be the “game changer” against COVID. Read More
Related Articles
A tech IPO in time for Valentine’s Day
This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. IPO investors seem to think they’ve found a true match with dating app company Bumble. The company behind Badoo and the Bumble app raised $2.2 billion in an offering […]
Trump tries to ban transactions with Chinese payment apps
President Donald Trump signed an order banning U.S. transactions with eight digital Chinese payment platforms including Ant Group’s Alipay in 45 days, when he’ll no longer be in office. The order is the outgoing administration’s latest bid to use national security powers against China’s technology companies, but it will be up to President-elect Joe Biden to decide […]
Olympic track star Allyson Felix learned the power of saying ‘no’
The record-setting Olympian said ‘no’ when she spoke out about Nike. Now, she’s saying ‘yes.’ Read More